Home  »  Markets   »  The Futility of Ra Medical Systems Inc. (AMEX:RMED...

The Futility of Ra Medical Systems Inc. (AMEX:RMED)’s Fundamentals

Ra Medical Systems Inc. (AMEX:RMED) previous close was $3.55 while the outstanding shares total 2.90M. RMED’s shares traded lower over the last trading session, losing -0.28% on 05/14/21. The shares fell to a low of $3.35 before closing at $3.54. Intraday shares traded counted 1.92 million, which was -8.54% lower than its 30-day average trading volume of 1.77M. The stock’s Relative Strength Index (RSI) is 40.53, with weekly volatility at 26.24% and ATR at 0.64. The RMED stock’s 52-week price range has touched low of $3.25 and a $23.50 high.

Investors have identified the Medical Devices company Ra Medical Systems Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $11.61 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.

Ra Medical Systems Inc. (RMED) Fundamentals that are to be considered.

When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 19.92 million total, with 5.98 million as their total liabilities.

Is the stock of RMED attractive?

In related news, Director, ENQUIST WILLIAM R bought 5,263 shares of the company’s stock in a transaction that recorded on Nov 19. The purchase was performed at an average price of 5.82, for a total value of 30,622. As the purchase deal closes, the Director, Mejia Richard Jr now bought 1,000 shares of the company’s stock, valued at 5,820. Also, Director, Stafslien Joan bought 4,410 shares of the company’s stock in a deal that was recorded on Nov 19. The shares were cost at an average price of 5.67 per share, with a total market value of 25,002. Following this completion of disposal, the Director, COLOMBATTO MARTIN J now holds 8,700 shares of the company’s stock, valued at 50,279. In the last 6 months, insiders have changed their ownership in shares of company stock by 7.90%.

Leave a Comment

Your email address will not be published. Required fields are marked *